SCHEMBL19497948

SCHEMBL19497948

CCCc1ccc(-c2ccc(O)c(C=N)c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.55
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
ALOX5 P09917 3/20 0.45
GABRA1 P14867 1/20 0.40
GABRB2 P47870 1/20 0.40
TRPA1 O75762 1/20 0.39
ERN1 O75460 4/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
DRD2 P14416 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19497905 0.84 MCL1 (0.59) MCL1CNR1CNR2ERN1
SCHEMBL18904621 0.82 MCL1 (0.42) MCL1CNR1CNR2ALOX5GPR84
SCHEMBL28740702 0.79 MCL1 (0.65) MCL1CNR1CNR2ALOX5TRPA1
SCHEMBL2941544 0.76 MCL1 (0.61) MCL1CNR1CNR2ALOX5GABRA1
SCHEMBL23491306 0.75 TRPA1 (0.63) CNR1CNR2ALOX5TRPA1CYP3A4
SCHEMBL10435290 0.75 MCL1 (0.59) MCL1CNR1CNR2ALOX5CYP3A4
SCHEMBL10880912 0.74 CDK1 (0.62) MCL1ERN1
SCHEMBL4802707 0.72 LPL (0.54) MCL1CNR1CNR2TSHRHSD17B10
SCHEMBL28685432 0.71 MCL1 (0.55) MCL1CNR1CNR2ALOX5GABRA1
SCHEMBL27538566 0.71 MCL1 (0.77) MCL1CNR1CNR2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723952-B2 Polymerizable compound and optically anisotropic body DIC CORPORATION (JP) 2020-07-28 US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 US disclosed
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170306233-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY SMC4, PHOSPHO1, SMCHD1 MCL1 4139/4885CNR1 3377/4885CNR2 3764/4885
US-10723952-B2 Polymerizable compound and optically anisotropic body SMC4, SMCHD1, PHOSPHO1 MCL1 4174/4885CNR1 3263/4885CNR2 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.